# Biolife Solutions Inc. (BLFS)

**Exchange:** NASDAQ  
**Sector:** Healthcare  
**Market cap:** $1.29B  
**Price:** $26.60 (-0.23%)

> Biolife Solutions Inc. is a leading provider of cell and gene therapy bioproduction tools and services. It specializes in offering biopreservation media, automated thawing devices, and storage solutions that are essential for preserving and transporting biological materials. The company's products help enhance the quality and stability of biological samples, which is crucial in sectors like regenerative medicine, biobanking, and drug discovery. By ensuring the safe handling and preservation of cells, tissues, and organs, Biolife Solutions plays a pivotal role in supporting life science research and clinical applications. The company's innovations contribute significantly to advancing therapeutic research and the development of treatments, thereby impacting the healthcare industry extensively. Headquartered in Bothell, Washington, Biolife Solutions Inc. is strategically positioned in the market, facilitating the evolving needs of the biopharmaceutical sector worldwide.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $96M | $62M | -$17M | -$5M | — |
| 2024 | $75M | $50M | -$4M | -$20M | — |
| 2023 | $68M | $41M | -$17M | -$68M | — |
| 2022 | $76M | — | -$6M | -$140M | — |
| 2021 | $119M | — | -$35M | -$9M | — |
| 2020 | $48M | — | -$6M | $2M | — |
| 2019 | $27M | $19M | -$220,000 | -$2M | — |
| 2018 | $20M | $14M | $4M | -$25M | — |
| 2017 | $11M | $7M | -$1M | -$3M | — |
| 2014 | $6M | $3M | -$3M | -$3M | — |
| 2013 | $9M | $4M | -$285,357 | -$1M | — |
| 2012 | $6M | $2M | -$942,238 | -$2M | — |
| 2011 | $3M | $1M | -$1M | -$2M | — |
| 2010 | $2M | $856,388 | -$1M | -$2M | — |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $406M | $34M | $372M | $33M | $5M |
| 2024 | $399M | $51M | $349M | $92M | $16M |
| 2023 | $413M | $75M | $338M | $28M | $24M |
| 2022 | $450M | $86M | $364M | $19M | $26M |
| 2021 | $554M | $76M | $478M | $70M | $7M |
| 2020 | $235M | $30M | $204M | $90M | $1M |
| 2019 | $93M | $49M | $43M | $6M | $13,000 |
| 2018 | $45M | $31M | $15M | $31M | — |
| 2017 | $12M | $2M | -$10M | $7M | — |
| 2014 | $16M | $2M | $14M | $3M | — |
| 2013 | $3M | $17M | -$13M | $156,273 | — |
| 2012 | $3M | $16M | -$12M | $196,478 | — |
| 2011 | $2M | $13M | -$11M | $16,864 | — |
| 2010 | $1M | $11M | -$10M | $3,211 | — |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | $20M | $9M | $11M |
| 2024 | $8M | $3M | $5M |
| 2023 | -$12M | $6M | -$19M |
| 2022 | -$8M | $10M | -$19M |
| 2021 | -$5M | $8M | -$13M |
| 2020 | $7M | $2M | $5M |
| 2019 | $1M | $675,000 | $538,000 |
| 2018 | $2M | $500,000 | $2M |
| 2017 | $605,000 | $144,000 | $461,000 |
| 2016 | -$4M | $143,533 | -$4M |
| 2015 | -$5M | $134,012 | -$5M |
| 2014 | -$3M | $589,680 | -$4M |
| 2013 | $146,007 | $236,670 | -$90,663 |
| 2012 | $854,934 | $1M | -$296,786 |
| 2011 | -$989,917 | $93,530 | -$1M |

Source: [CompaniesByCap](https://companiesbycap.com/company/BLFS)